Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Henry Schein announces KKR investment, prelim. Q4 sales (update)
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...
Strategic Investment and Growth Potential Drive Buy Rating for Henry Schein Despite Underwhelming Guidance
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein Sees 4Q EPS Growth as it Confirms KKR Minority-Stake Deal
Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...
Hold Rating Maintained for Henry Schein Amid Strategic Investment by KKR and Soft Operational Performance
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...